Clinical Trials Directory

Trials / Unknown

UnknownNCT04525677

Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In the diagnosis and treatment of patients with sepsis, through routine stool testing and dynamic testing of coagulation function, we found that patients often have stools that are not formed, the proportion of main fecal bacteria is imbalanced, the level of blood bacterial toxins rises, and the abnormal coagulation status indicate the gut microbiome dysbiosis may play an important regulatory role in abnormal blood coagulation in patients with sepsis. Therefore, we propose that the gut microbiome dysbiosis is involved in sepsis-induced coagulopathy. This project intends to prospectively observe the changes in gut microbiome dysbiosis and blood coagulation function in patients with sepsis before and after treatment, and explore whether the changes in gut microbiome dysbiosis promote the development of sepsis through coagulation disorders, provide new research perspectives for diagnosis and treatment for sepsis.

Conditions

Timeline

Start date
2020-07-15
Primary completion
2021-07-15
Completion
2021-07-15
First posted
2020-08-25
Last updated
2020-08-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04525677. Inclusion in this directory is not an endorsement.